Clinical Trials for Anthos Therapeutics

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Anthos Therapeutics

Clinical Trials (4)

NCT05712200
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
PHASE3Recruiting
1,900 participants
Started: Dec 27, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor605 locations
NCT05171075
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
PHASE3Recruiting
1,020 participants
Started: Sep 27, 2022 · Completed: Feb 28, 2027
3 conditions2 sponsors185 locations
NCT05171049
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
PHASE3Active, not recruiting
1,150 participants
Started: May 5, 2022 · Completed: Feb 28, 2027
3 conditions2 sponsors209 locations
NCT04755283
Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
PHASE2Active, not recruiting
1,287 participants
Started: Feb 2, 2021 · Completed: Dec 29, 2028
2 conditions3 sponsors92 locations